和誉-B：匹米替尼III期临床试验结果公布，数据优异静待商业化推进
02256和誉-B(02256) 天风证券·2024-11-13 21:27

港股公司报告 | 公司点评 | --- | --- | --- | |-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------|-------- ...